Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes
- PMID: 15583118
- DOI: 10.1001/archpsyc.61.12.1271
Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes
Abstract
Background: Although brain serotonin transporter (5-HTT) density has been investigated in subjects with a history of major depressive episodes (MDE), there has never been an investigation of brain 5-HTT during a current MDE. Brain 5-HTT binding potential (BP) may have an important role during MDE due to major depressive disorder, because the 5-HTT regulates extracellular 5-HT. The BP is an index of receptor density. Carbon 11-labeled 3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile (DASB) positron emission tomography (PET) is the first brain imaging technique that can measure the 5-HTT BP in cortical and subcortical brain regions in vivo. The purposes of this study were to investigate 5-HTT BP during MDE and to determine the relationship between 5-HTT BP and negativistic dysfunctional attitudes during MDE. Dysfunctional attitudes are negatively biased assumptions and beliefs regarding oneself, the world, and the future. Our recent publication of increased serotonin2 BP in MDE with severely negativistic dysfunctional attitudes suggests that this subgroup of MDE subjects has very low levels of extracellular serotonin.
Methods: Regional 5-HTT BP was measured in 20 nonsmoking medication-free (> or =3 months) depressed subjects and 20 age-matched nonsmoking, medication-free, healthy subjects using [11C]DASB PET. Dysfunctional attitudes were measured using the Dysfunctional Attitudes Scale.
Results: No difference in regional 5-HTT BP was found between MDE and healthy subjects; however, the subgroup of MDE subjects with highly negativistic dysfunctional attitudes had significantly higher 5-HTT BP compared with healthy subjects in brain regions mainly sampling serotonergic nerve terminals (prefrontal cortex, anterior cingulate, thalamus, bilateral caudate, and bilateral putamen; average, 21% greater; F(1,26), 5.6-12.2 [P values, .03-.002]). In the MDE subjects, increased 5-HTT BP was strongly associated with more negativistic dysfunctional attitudes in brain regions primarily sampling serotonergic nerve terminals (prefrontal cortex, anterior cingulate, thalamus, caudate, and putamen; r = 0.64-0.74 [P values, .003 to <.001]).
Conclusions: Serotonin transporters play an important role during depression. The magnitude of regional 5-HTT BP can provide a vulnerability to low levels of extracellular serotonin and symptoms of extremely negativistic dysfunctional attitudes.
Similar articles
-
Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.Biol Psychiatry. 2007 Oct 15;62(8):870-7. doi: 10.1016/j.biopsych.2007.03.016. Epub 2007 Aug 2. Biol Psychiatry. 2007. PMID: 17678634
-
Imaging the serotonin transporter during major depressive disorder and antidepressant treatment.J Psychiatry Neurosci. 2007 Mar;32(2):86-102. J Psychiatry Neurosci. 2007. PMID: 17353938 Free PMC article. Review.
-
Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.J Psychiatr Res. 2008 Oct;42(14):1137-44. doi: 10.1016/j.jpsychires.2008.01.012. Epub 2008 Mar 10. J Psychiatr Res. 2008. PMID: 18331740 Free PMC article.
-
Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans.Synapse. 2005 Mar 1;55(3):164-75. doi: 10.1002/syn.20105. Synapse. 2005. PMID: 15605360 Clinical Trial.
-
Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.World J Biol Psychiatry. 2002 Jul;3(3):133-46. doi: 10.3109/15622970209150614. World J Biol Psychiatry. 2002. PMID: 12478878 Review.
Cited by
-
ITI-007 demonstrates brain occupancy at serotonin 5-HT₂A and dopamine D₂ receptors and serotonin transporters using positron emission tomography in healthy volunteers.Psychopharmacology (Berl). 2015 Aug;232(15):2863-72. doi: 10.1007/s00213-015-3922-1. Epub 2015 Apr 7. Psychopharmacology (Berl). 2015. PMID: 25843749
-
Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.Psychopharmacology (Berl). 2007 Sep;193(4):539-45. doi: 10.1007/s00213-007-0806-z. Epub 2007 May 12. Psychopharmacology (Berl). 2007. PMID: 17497139 Clinical Trial.
-
Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.Brain. 2010 Jun;133(Pt 6):1779-97. doi: 10.1093/brain/awq103. Epub 2010 May 17. Brain. 2010. PMID: 20483717 Free PMC article.
-
Potential Mechanism for HIV-Associated Depression: Upregulation of Serotonin Transporters in SIV-Infected Macaques Detected by 11C-DASB PET.Front Psychiatry. 2019 May 23;10:362. doi: 10.3389/fpsyt.2019.00362. eCollection 2019. Front Psychiatry. 2019. PMID: 31178771 Free PMC article.
-
Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys.Neuropsychopharmacology. 2008 Jan;33(2):219-25. doi: 10.1038/sj.npp.1301420. Epub 2007 Apr 18. Neuropsychopharmacology. 2008. PMID: 17443127 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources